251658-58-9

Basic information

• Product Name: 5-(PYRIDIN-3-YL)-1H-PYRAZOLE-3-CARBOXYLIC ACID ETHYL ESTER
• Synonyms: 5-(PYRIDIN-3-YL)-1H-PYRAZOLE-3-CARBOXYLIC ACID ETHYL ESTER;Ethyl 5-(pyridin-3-yl)-1H-pyrazole-3-carboxylate ,97%;Ethyl 5-(pyridin-3-yl)-1H-pyrazole-3-carboxylate;1H-Pyrazole-3-carboxylic acid, 5-(3-pyridinyl)-, ethyl ester;5-Pyridin-3-yl-2H-pyrazole-3-carboxylicacidethylester
• CAS NO: 251658-58-9
• Molecular Formula: C₁₁H₁₁N₃O₂
• Molecular Weight: 217.22394
• Mol File: 251658-58-9.mol
• Article Data: 7

Chemical Properties

• Melting Point: 162-163 °C
• Boiling Point: 455.9±35.0 °C(Predicted)
• Appearance: /
• Density: 1.249±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 9.20±0.10(Predicted)
• CAS DataBase Reference: 5-(PYRIDIN-3-YL)-1H-PYRAZOLE-3-CARBOXYLIC ACID ETHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 5-(PYRIDIN-3-YL)-1H-PYRAZOLE-3-CARBOXYLIC ACID ETHYL ESTER(251658-58-9)
• EPA Substance Registry System: 5-(PYRIDIN-3-YL)-1H-PYRAZOLE-3-CARBOXYLIC ACID ETHYL ESTER(251658-58-9)

Safety Data

• Statements: 20/21/22-36/37/38
• Safety Statements: 3/9-36/37
• Hazardous Substances Data: 251658-58-9(Hazardous Substances Data)

Usage

Chemical Properties

Off-white solid

Upstream product

• 2510-23-8 3-Ethynylpyridine 
• 623-73-4 diazoacetic acid ethyl ester 
• 350-03-8 methyl-3-pyridylketone 
• 92288-94-3 2,4-dioxo-4-pyridin-3-ylbutyric acid ethyl ester 

Downstream Products

• 374064-01-4 3-(pyridin-3-yl)-1H-pyrazole-5-carboxylic acid 
• 287494-01-3 5-(pyridin-3-yl)-1H-pyrazole-3-carboxamide 
• 287494-03-5 (5-pyridin-3-yl-1H-pyrazol-3-yl)-methanol 
• 23424-35-3 5-(3-pyridyl)pyrazole-3-carboxylic acid hydrazide 

Relevant articles and documents

Synthesis, structure–activity relationships and biological evaluation of 4,5,6,7-tetrahydropyrazolopyrazines as metabotropic glutamate receptor 5 negative allosteric modulators

The design, synthesis and SAR studies of novel 4,5,6,7-tetrahydropyrazolopyrazines as metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulators (NAMs) are presented in this letter. Starting from a HTS hit compound (1, IC50?=?477

PYRAZOLE COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATMENT OF DEGENERATIVE DISEASES AND DISORDERS

Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful

NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-COA DESATURASE

The present invention relates to piperazine derivatives that act as inhibitors of stearoyl-CoA desaturase. The invention also relates to methods of preparing the compounds, compositions containing the compounds, and to methods of treatment using the compounds.